Innovative digital self-management for Type 2 diabetes
Official title: Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age
Run by Scripps Whittier Diabetes Institute · NCT05416060 · Data updated 2026-11-12
This study is testing a new digital program to help underserved Hispanic and Latino adults with Type 2 diabetes manage their health better using mobile technology and group support.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Scripps Whittier Diabetes Institute Academic / other |
| Locations | 2 sites (Chula Vista, California and 1 other locations) |
| Status | Recruiting |
| Started | March 23, 2023 |
| Main results expected | December 31, 2026 |
| Study ends | June 30, 2027 |
| Registry record updated | June 17, 2026 |
| Trial ID | NCT05416060 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Hispanic/Latino adults with Type 2 diabetes and an HbA1c of 8% or higher who are registered patients of Scripps Health.
✕Probably not a fit
Patients with severe illnesses, low literacy, or those not willing to use a mobile phone may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Dulce Digital 2.0 aims to enhance diabetes self-management among underserved Hispanic/Latino adults through mobile health (mHealth) technologies. The program includes telehealth group visits, text-based education, and live sessions to improve health literacy and clinical outcomes. By leveraging digital platforms, the initiative seeks to increase access to vital health information and support, ultimately addressing health disparities in diabetes care. The approach builds on previous successful interventions and is designed to be scalable for broader implementation.
Why it matters
Potential benefit: If successful, this program could significantly improve diabetes management and health outcomes for underserved populations.
How similar studies have gone: Previous studies have shown success with similar telehealth and mHealth interventions in improving diabetes management.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Hispanic/Latino adults who are registered patients of Scripps Health * Diagnosis of Type 2 Diabetes * HbA1c greater than or equal to 8% within the last 60 days Exclusion Criteria: * Severe illness precluding visits to clinic * Liver function tests (ALT and AST) \> 3 times the upper limit of normal * Body mass index ≤ 23 kg/cm * History of malignancy, except subjects who have been disease-free for \>2 years, or whose only malignancy has been basal or squamous cell skin carcinoma * Creatinine \>3.5 * History of drug or alcohol abuse within 12 months prior to randomization * Current enrollee in DSME/S * Blood donation of one pint or more within the past 30 days, or plasma donation within 7 days prior to screening * Anemia * Lack of minimal literacy needed to participate in the text intervention * Severe auditory or visual problems * Primary language other than Spanish or English * Not willing to carry a mobile phone * Pregnant * Plans to relocate
Where it's running
-
Scripps Chula Vista Diabetes Center
Chula Vista, California, United States Recruiting -
Scripps Whittier Diabetes Institute
San Diego, California, United States Recruiting
Study contacts
- Principal investigator: Athena Philis-Tsimikas, MD — Scripps Health
- Study coordinator: Athena Philis-Tsimikas, MD
- Email: philis-tsimikas.athena@scrippshealth.org
- Phone: 858-678-7046
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cardio-Metabolic Clinic care for adults with type 2 diabetes and cardiovascular disease
This trial tests whether a specialized Cardio-Metabolic Clinic can improve heart function and overall health for adults with type 2 diabetes and cardiovascular disease compared with usual care.
-
See if short-term supervised resistance training improves muscle health and function in frail older adults with type 2 diabetes
This study tests whether a brief, supervised resistance training program can improve skeletal muscle health and physical function in frail adults over 65 who have type 2 diabetes.
-
Empagliflozin, Metformin, or both for muscle energy in adults with type 2 diabetes
This study tests whether empagliflozin, metformin, or their combination can improve skeletal muscle oxidative capacity and microvascular reactivity in adults recently diagnosed with type 2 diabetes.
-
Perioperative Meditation Music for Type 2 Diabetes Patients Undergoing Elective Surgery
We’re testing whether playing self-selected meditation music around surgery helps adults with type 2 diabetes stay calm, sleep better, and keep blood sugar steadier.
-
How metformin works in people with or without the SLC16A11 risk variant
This study tests whether the SLC16A11 genetic variant changes how adults with type 2 diabetes respond to metformin over 6 months.
-
Remote-patient monitoring in diabetes care shows real-world outcomes
A real-world, pre-post observational study at Steno Diabetes Center Copenhagen tests whether adding remote-patient-monitoring within the EHR can maintain glycemic outcomes over two years for about 12,000 people with diabetes compared with prior ambulatory care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.